Found 5 matching trials
A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease
PHASE1This is a Phase I study to investigate the safety and tolerability of AZD48...
Study to Assess the Effect of AZD4831 on the Pharmacokinetics (Drug Behavior in the Body) of Midazolam
PHASE1The study is an open-label, fixed-sequence, cross-over study conducted at a...
Myeloperoxidase (MPO) Inhibitor A_Zeneca for Heart Failure With Preserved Ejection Fraction (HFpEF)
PHASE1Researchers are studying the effect of a single dose of oral myeloperoxidas...
Location
Mayo Clinic in Rochester
An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD.
PHASE2This is a research study to evaluate the efficacy and safety of the investi...
A Study to Assess the Pharmacokinetics of AZD4831 When Administered Alone and in Combination With Itraconazole
PHASE1A study to demonstrate pharmacokinetics of AZD4831 when administered alone ...